These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36866403)

  • 21. Malignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation.
    Nix JS; Haffner MC; Ahsan S; Hicks J; De Marzo AM; Blakeley J; Raabe EH; Rodriguez FJ
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):958-963. PubMed ID: 30169729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
    Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
    J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA cytofluorometric analysis of benign and malignant nerve sheath tumors.
    Tsuji Y; Kusuzaki K; Kuzuhara A; Murata H; Takeshita H; Hirata M; Hashiguchi S; Hirasawa Y; Ashihara T
    Anticancer Res; 2000; 20(6C):4691-6. PubMed ID: 11205202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
    Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2.
    Halliday AL; Sobel RA; Martuza RL
    J Neurosurg; 1991 Feb; 74(2):248-53. PubMed ID: 1846409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
    Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
    AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
    Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
    Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart.
    Agaram NP; Wexler LH; Chi P; Antonescu CR
    Genes Chromosomes Cancer; 2023 Mar; 62(3):131-138. PubMed ID: 36414547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
    Guha D; Davidson B; Nadi M; Alotaibi NM; Fehlings MG; Gentili F; Valiante TA; Tator CH; Tymianski M; Guha A; Zadeh G
    J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral nerve sheath tumors arising in salivary glands: A clinicopathologic study.
    Guraya SS; Prayson RA
    Ann Diagn Pathol; 2016 Aug; 23():38-42. PubMed ID: 27402223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
    Tajima S; Koda K
    Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
    Karube K; Nabeshima K; Ishiguro M; Harada M; Iwasaki H
    J Clin Pathol; 2006 Feb; 59(2):160-5. PubMed ID: 16443732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
    Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
    Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?
    Debs P; Luna R; Fayad LM; Ahlawat S
    Skeletal Radiol; 2024 Apr; 53(4):709-723. PubMed ID: 37845504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.
    Hruska A; Bollmann R; Kovács RB; Bollmann M; Bodó M; Sápi Z
    Cell Oncol; 2004; 26(5-6):335-45. PubMed ID: 15623944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathologic characteristics of the most frequent peripheral nerve tumors].
    Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
    Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Significance of Ki67 Staining Pattern in Benign Peripheral Nerve Sheath Tumors: An Additional Diagnostic Tool.
    Doğukan FM; Erdem ZB
    Int J Surg Pathol; 2023 Oct; 31(7):1225-1231. PubMed ID: 36475929
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
    Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
    Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.